Nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme in mammalian NAD+ biosynthesis, has been found to have a positive effect on ischemic stroke treatment. The gene discussed is NAMPT; the disease is ischemic stroke.